Jane Street
RVMD icon

Jane Street’s Revolution Medicines RVMD Stock Holding History

Jane Street’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.5M Buy
138,600
+52,600
+61% +$5.31M ﹤0.01% 2177
2025
Q4 		$6.85M Buy
86,000
+9,600
+13% +$629K ﹤0.01% 2789
2025
Q3 		$3.57M Buy
76,400
+39,300
+106% +$1.54M ﹤0.01% 3941
2025
Q2 		$1.36M Buy
37,100
+21,200
+133% +$814K ﹤0.01% 5058
2025
Q1 		$562K Sell
15,900
-123,400
-89% -$5.01M ﹤0.01% 6647
2024
Q4 		$6.09M Buy
139,300
+115,600
+488% +$5.83M ﹤0.01% 2421
2024
Q3 		$1.07M Buy
23,700
+2,100
+10% +$91.4K ﹤0.01% 5740
2024
Q2 		$838K Buy
21,600
+9,700
+82% +$363K ﹤0.01% 6106
2024
Q1 		$384K Sell
11,900
-1,000
-8% -$29.6K ﹤0.01% 7153
2023
Q4 		$370K Sell
12,900
-124,000
-91% -$2.98M ﹤0.01% 7295
2023
Q3 		$3.79M Buy
+136,900
New +$4.06M ﹤0.01% 3015
2023
Q2 		– Sell
-126,500
Closed -$2.74M – 9458
2023
Q1 		$2.74M Buy
126,500
+62,500
+98% +$1.54M ﹤0.01% 3297
2022
Q4 		$1.52M Buy
+64,000
New +$1.36M ﹤0.01% 4292
2022
Q2 		– Sell
-108,500
Closed -$2.77M – 10705
2022
Q1 		$2.77M Buy
+108,500
New +$2.36M ﹤0.01% 4124

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Jane Street's RVMD Position: Q1 2026 in Review

Jane Street reduced its Revolution Medicines (RVMD) stake by 97% in Q1 2026, selling an estimated $107M and leaving 33,603 shares worth $3.27M. The position accounts for ﹤0.01% of the portfolio, ranked #4189.

Jane Street first reported a position in RVMD in Q1 2021 and has held it in 18 quarters since. The position peaked at $86.9M in Q4 2025. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Jane Street held 33,603 shares of Revolution Medicines worth $3.27M as of Q1 2026.
  • Jane Street sold 1,056,813 Revolution Medicines shares in Q1 2026, an estimated $107M.
  • Revolution Medicines made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #4189 holding.
  • Jane Street first reported a position in Revolution Medicines in Q1 2021 and has held it in 18 quarters since.
  • Jane Street's Revolution Medicines position peaked at $86.9M in Q4 2025.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.